Brett Sandercock - 10 Jun 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Issuer symbol
RMD
Transactions as of
10 Jun 2021
Net transactions value
-$532,100
Form type
4
Filing time
14 Jun 2021, 09:53:59 UTC
Previous filing
11 May 2021
Next filing
13 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale $532,100 -2,500 -2.7% $212.84 90,002 10 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.